The Clinical Outcome of UK Military Personnel Who Received a Massive Transfusion in Afghanistan During 2009

Abstract

The use of the current MTP was associated with a high rate of survival. Survivors require a continuity of critical care with a median demand for 3 days. The early use of plasma and platelets can be successfully delivered in the battlefield despite operational and logistic constraints.